Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
18641-57-1
Name of the chemical
glycerol tribehenate
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
9050-36-6
Name of the chemical
Maltodextrin
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
N/A
EC/CAS
232-940-4
Name of the chemical
Maltodextrin
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2020-05-20
Product name
REQUIP-MODUTAB PROLONGED RELEASE TABLETS
Product Synonyms
REQUIP LP * REQUIP XL * REQUIP DEPOT * REQUIP-MODUTAB * REQUIP PROLONGED
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended. Hazard summary Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
HYDROXYPROPYL METHYL CELLULOSE, MAGNESIUM STEARATE, MALTODEXTRIN, ROPINIROLE HYDROCHLORIDE, Silicon dioxide, Titanium dioxide, TRIBEHENIN
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Prevention
Not available.
Response
Not available.
Storage
Not available.
Disposal
Not available.
Supplemental label elements
24.685 % of the mixture consists of component(s) of unknown acute oral toxicity. 85.935 % of the mixture consists of component(s) of unknown acute dermal toxicity. 83.435 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 80.135 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
